Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Oncology|Melanoma|Ovarian Cancer|NSCLC|Non Small Cell Lung Cancer|Colorectal Cancer|Pancreatic Cancer|Cancer|CRC|Colon Cancer|Breast Cancer|Gastric Cancer|EGJ|Esophagogastric Junction Cancer|Head and Neck Cancer|Urothelial Cancer|Bladder Cancer
Interventions: BIOLOGICAL: E-602|BIOLOGICAL: Cemiplimab
Sponsor: Palleon Pharmaceuticals, Inc.